tirzepatide losing effectiveness Semaglutide vs Tirzepatide: Which GLP-1 Wins for Weight Loss? How Tirzepatide Helped A 24

although it is generally considered to be associated with an unacceptably high incidence of lactic acidosis, often fatal, it is still available in some countries

doi: 10.2337/db09-1414 76 LinnebjergHParkSKotharePATrautmannMEMaceKFinemanMet al

Key Research Findings Clinical Research : Has identified specific risk patterns among different patient populations: Diabetic patients using GLP-1 drugs showed a 4.28-fold increased risk of developing NAION compared to those on alternative diabetes medications Overweight or obese patients prescribed these agents demonstrated a 7.64-fold elevated risk relative to individuals using other weight management therapies The cumulative incidence rate suggested approximately 8.9 cases per 10,000 patient-years among GLP-1 receptor agonist users Additional Studies: Documented in medical literature have examined various eye manifestations beyond NAION

Mounjaro provides metabolic, cardiovascular, and blood glucose benefits beyond weight loss alone

If you are losing weight and feeling good on the lowest dose, stay there